DME Offers New Education Series for INTERPHEX 2016

Share Article

Surveys to Focus on Industry Trends and New Technologies in Biopharmaceutical Manufacturing

News Image
“This is a prime opportunity to poll those who work within the industry and respond to everyday challenges regarding the adoption of new technologies and priorities when expanding or updating their facilities.

DME is pleased to announce its participation in next year’s INTERPHEX 2016 Technical Education Program. The program, entitled DME Facility Focus, encompasses feedback and analysis regarding the latest industry trends and technologies affecting manufacturing facilities in the life sciences sector. Based on survey data derived from polling a range of professionals across the industry, DME engineers and industry experts will provide analysis and insight into the future of cGMP facilities, as well as practical guidance on how new technologies can transform current manufacturing operations. Participation in the surveys is being extended to engineers, manufacturers, and other experts in the biopharmaceutical industry.

Two tracks will be available: Biopharmaceutical Facility Modernization and Aseptic Manufacturing Technology Trends. Biopharmaceutical Facility Modernization will focus on current trends and technologies available to transform legacy facilities, in order to enhance bio-manufacturing flexibility and ensure the reliability of the drug substance supply train. Topics include process automation, single-use, closed processing, continuous processing, facility segregation, and risk management. Aseptic Manufacturing Technology Trends will focus on sterile manufacturing technology trends that manage risk and enhance product quality in parenteral fill/finish facilities. Topics include implementation of barrier isolation/RABS, single-use, serialization, and product protection.

According to Dave Marks, P.E. and President of DME, “This is a prime opportunity to poll those who work within the industry and respond to everyday challenges regarding the adoption of new technologies and priorities when expanding or updating their facilities. We wanted to collaborate with INTERPHEX because it is the leading show where industry leaders come to learn, discuss, and make decisions regarding the future of their development and manufacturing facilities.”

About INTERPHEX

INTERPHEX (International Pharmaceutical Expo), sponsored by Parenteral Drug Association (PDA), is the single source for complete development and manufacturing solutions to safely and cost effectively process all dosage forms for life-enhancing drugs. It brings over 10,000 global pharmaceutical and biotechnology professionals together with 600+ suppliers through a unique combination of exhibition, education, workshops, partnering opportunities, and networking events. INTERPHEX offers annual national and international industry events and educational opportunities around the world. To continue the Innovation, Technologies and Knowledge beyond the show floor, visit http://www.INTERPHEX.com and follow INTERPHEX on Facebook, LinkedIn, Twitter, IPX Blog, and YouTube.

About DME, Engineering Solutions for Life

Celebrating its 15th year in business, DME provides a wide array of engineering solutions for the biotechnology, pharmaceutical, medical device, science & technology, food & beverage, and chemical process industries. Our services include advanced technology facility design, MEP Engineering, Process Engineering, Operations Improvement, and related consulting services. We are an excellent fit for projects requiring GMP manufacturing, cleanroom environments, or hygienic process technology. Our company leverages strong relationships with process architecture and construction management partners to deliver ‘engineering solutions for life’. Clients select DME because of our deep industry knowledge, professionalism, and team approach. For more information, visit http://www.DMEForLife.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Francine Carb

Mark Matson
DME
6103661744 147
Email >
Visit website